Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor

Laura J Cobb1, Bingrong Liu, Kuk-Wha Lee

  • 1Division of Pediatric Endocrinology, Mattel Children's Hospital at University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California, USA.

Cancer Research
|November 17, 2006
PubMed

Insights

Insulin-like growth factor binding protein-3 (IGFBP-3) requires DNA-dependent protein kinase (DNA-PK) activity to promote cancer cell apoptosis. Phosphorylation at Serine 156 by DNA-PK is critical for IGFBP-3

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Insulin-like growth factor binding protein-3 (IGFBP-3) induces cancer cell apoptosis via IGF-dependent and -independent pathways.
  • DNA-dependent protein kinase (DNA-PK) can phosphorylate IGFBP-3 in vitro, but its functional significance remains unclear.

Purpose of the Study:

  • To investigate the functional role of DNA-PK in mediating the anti-cancer effects of IGFBP-3.
  • To identify specific phosphorylation sites on IGFBP-3 critical for its activity.

Main Methods:

  • Utilized a DNA-PK chemical inhibitor in prostate cancer cells.
  • Employed glioblastoma cell lines with and without DNA-PK expression.
  • Performed site-directed mutagenesis on potential DNA-PK phosphorylation sites in IGFBP-3.

Main Results:

  • IGFBP-3's apoptosis-promoting and growth-inhibitory effects were abolished without active DNA-PK.
  • IGFBP-3 showed reduced nuclear accumulation and impaired retinoid X receptor alpha (RXRα) binding in the absence of DNA-PK activity.
  • Mutating Serine 156 (IGFBP-3-S156A) abrogated apoptosis promotion and reduced nuclear localization, unlike mutations at Serine 165 or Threonine 170.

Conclusions:

  • DNA-PK activity is essential for IGFBP-3's pro-apoptotic and anti-proliferative functions in cancer cells.
  • Phosphorylation of IGFBP-3 by DNA-PK, particularly at Serine 156, is a key regulatory mechanism for its nuclear actions and anti-cancer effects.
  • This identifies a novel pathway for regulating IGFBP-3 activity in prostate cancer treatment strategies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...